Clinical Trial

Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke

Study acronym: ARTS-SAFE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to explore the safety and efficacy of different dose of Anakinra compared to standard medical care for patients with acute ischemic stroke who have achieved successful recanalization after endovascular thrombectomy.
Trial Details
NCT Number NCT07423975
Lead Sponsor Beijing Tiantan Hospital
Conditions Stroke Acute, Endovascular Treatment
Enrollment 159 participants
Start Date 2026-03-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-20